title: Airway basement membrane perimeter in human airways is not a constant; potential implications for airway remodeling in asthma.
abstract: Many studies that demonstrate an increase in airway smooth muscle in asthmatic patients rely on the assumption that bronchial internal perimeter (P(i)) or basement membrane perimeter (P(bm)) is a constant, i.e., not affected by fixation pressure or the degree of smooth muscle shortening. Because it is the basement membrane that has been purported to be the indistensible structure, this study examines the assumption that P(bm) is not affected by fixation pressure. P(bm) was determined for the same human airway segment (n = 12) fixed at distending pressures of 0 cmH(2)O and 21 cmH(2)O in the absence of smooth muscle tone. P(bm) for the segment fixed at 0 cmH(2)O was determined morphometrically, and the P(bm) for the same segment, had the segment been fixed at 21 cmH(2)O, was predicted from knowing the luminal volume and length of the airway when distended to 21 cmH(2)O (organ bath-derived P(i)). To ensure an accurate transformation of the organ bath-derived P(i) value to a morphometry-derived P(bm) value, had the segment been fixed at 21 cmH(2)O, the relationship between organ bath-derived P(i) and morphometry-derived P(bm) was determined for five different bronchial segments distended to 21 cmH(2)O and fixed at 21 cmH(2)O (r(2) = 0.99, P < 0.0001). Mean P(bm) for bronchial segments fixed at 0 cmH(2)O was 9.4 +/- 0.4 mm, whereas mean predicted P(bm), had the segments been fixed at 21 cmH(2)O, was 14.1 +/- 0.5 mm (P < 0.0001). This indicates that P(bm) is not a constant when isolated airway segments without smooth muscle tone are fixed distended to 21 cmH(2)O. The implication of these results is that the increase in smooth muscle mass in asthma may have been overestimated in some previous studies. Therefore, further studies are required to examine the potential artifact using whole lungs with and without abolition of airway smooth muscle tone and/or inflation.
authors.affiliation: Department of Pharmacology, University of Sydney, New South Wales, Australia. brentmcparland@hotmail.com
authors.forename: Brent E
authors.initials: BE
authors.lastname: McParland
authors.forename: Peter D
authors.initials: PD
authors.lastname: Paré
authors.forename: Peter R A
authors.initials: PR
authors.lastname: Johnson
authors.forename: Carol L
authors.initials: CL
authors.lastname: Armour
authors.forename: Judith L
authors.initials: JL
authors.lastname: Black
mesh_terms: D001249:Asthma / Q000473:pathology* / Q000503:physiopathology; D001485:Basement Membrane / Q000473:pathology / Q000503:physiopathology; D001980:Bronchi / Q000473:pathology / Q000503:physiopathology; D016535:Bronchial Hyperreactivity / Q000473:pathology* / Q000503:physiopathology; D006801:Humans; D066298:In Vitro Techniques; D009130:Muscle, Smooth / Q000473:pathology* / Q000503:physiopathology; D010477:Perfusion